Expression of miR-155, miR-146a, and miR-326 in T1D patients from Chile: relationship with autoimmunity and inflammatory markers

Arch Endocrinol Metab. 2018 Feb;62(1):34-40. doi: 10.20945/2359-3997000000006.

Abstract

Objective The aim of this research was to analyze the expression profile of miR-155, miR-146a, and miR-326 in peripheral blood mononuclear cells (PBMC) of 47 patients with type 1 diabetes mellitus (T1D) and 39 control subjects, as well as the possible association with autoimmune or inflammatory markers. Subjects and methods Expression profile of miRs by means of qPCR using TaqMan probes. Autoantibodies and inflammatory markers by ELISA. Statistical analysis using bivariate correlation. Results The analysis of the results shows an increase in the expression of miR-155 in T1D patients in basal conditions compared to the controls (p < 0.001) and a decreased expression level of miR-326 (p < 0.01) and miR-146a (p < 0.05) compared T1D patients to the controls. miR-155 was the only miRs associated with autoinmmunity (ZnT8) and inflammatory status (vCAM). Conclusion Our data show a possible role of miR-155 related to autoimmunity and inflammation in Chilean patients with T1D.

MeSH terms

  • Autoantibodies / immunology
  • Autoantibodies / metabolism
  • Autoimmunity / immunology
  • Biomarkers
  • Case-Control Studies
  • Child
  • Diabetes Mellitus, Type 1 / blood
  • Diabetes Mellitus, Type 1 / immunology
  • Diabetes Mellitus, Type 1 / metabolism*
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Inflammation / immunology
  • Inflammation / metabolism
  • MicroRNAs / metabolism*
  • Real-Time Polymerase Chain Reaction

Substances

  • Autoantibodies
  • Biomarkers
  • MIRN146 microRNA, human
  • MIRN155 microRNA, human
  • MIRN326 microRNA, human
  • MicroRNAs

Grants and funding

This project was supported by FONDECYT Grant 1130240